Johns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street, Baltimore, MD 21205Offices & Services Alumni Giving Calendars Careers Contact Us ...

Looking to strengthen your next grant, translate your research into real-world solutions, or open new training and career pathways for students and postdocs? Join research@BSPH and the Innovation ...

Two new studies led by researchers at the Johns Hopkins Bloomberg School of Public Health shed light on current U.S. hospital practices. In one, the researchers found that the prices hospitals ...

* The data presented in the maps are compiled from official sources, including state and county health departments and additional county-level news releases or news articles, and represent ...

One of the best tools for preventing severe complications from COVID infection is the prescription antiviral drug Paxlovid. But not nearly as many people who could benefit from it are being prescribed ...

The hygiene hypothesis is the idea that kids need to be exposed to germs in order to develop healthy immune systems. We know that many common viruses did not circulate as widely during the pandemic, ...

The vast majority of vector-borne diseases in the U.S. are caused by ticks and the viruses, bacteria, and parasites they carry. Baumgarth, a professor in Molecular Microbiology and Immunology and ...

Receiving a diagnosis of a chronic illness can be life-altering. Along with the day-to-day physical symptoms of the illness, emotions such as sadness, grief, and denial, as well as an added financial ...

Harm reduction is exactly what it sounds like: reducing the harm associated with using drugs through a variety of public health interventions. But the concept relies on more than these tools and ...

In 1971, the FDA approved the measles-mumps-rubella (MMR) vaccine, which combined three vaccines that had been approved previously—in 1963, 1967, and 1969, respectively. The vaccine has proven safe ...

Public health agencies and governments across the globe are always readying their response for the next infectious disease emergency, but how do we prepare for the truly unknown? Enter Disease X.

A new study published in December in JAMIA Open and led by Department of Health Policy and Management researchers including Elham Hatef, MD, MPH, and Jonathan P. Weiner, DrPH, aims to address ...